Weight loss jabs could curb alcohol cravings and reduce drinking, study suggests
Researchers believe the drugs, known as GLP-1 receptor agonists, could curb alcohol cravings, although further investigation is needed.
These jabs, often prescribed under brand names like Saxenda (liraglutide) and Wegovy (semaglutide), work by suppressing appetite.
The study, conducted by researchers in Ireland and Saudi Arabia, observed 262 obese individuals prescribed either liraglutide or semaglutide.
Participants were categorised according to their pre-treatment weekly alcohol intake: non-drinkers, rare drinkers (less than 10 units per week), and regular drinkers (10 or more units per week).
Some 188 of the 262 patients were followed up for an average of four months.
Average alcohol consumption fell from 11.3 units a week – about six or seven pints of beer – to 4.3 units a week, or roughly two pints of beer, after four months on the drugs.
Among regular drinkers, intake decreased by 68 per cent, from 23.2 units a week to 7.8 units a week.
Professor Carel le Roux, of University College Dublin, said: 'The exact mechanism of how GLP-1 analogues reduce alcohol intake is still being investigated but it is thought to involve curbing cravings for alcohol that arise in subcortical areas of the brain that are not under conscious control.
'Thus, patients report the effects are 'effortless'.'
The findings, which are being presented at the European Congress on Obesity in Malaga, suggest a 'potential therapeutic role' for weight loss jabs in people who are obese and regularly drink alcohol, researchers said.
However, they stressed larger trials are needed to validate the results.
Prof Le Roux added: 'GLP-1 analogues have been shown treat obesity and reduce the risk of multiple obesity-related complications.
'Now, the beneficial effects beyond obesity, such as on alcohol intake, are being actively studied, with some promising results.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Serena Williams reveals she uses GLP-1 weight loss drug Zepbound: 'I just could never get back to where I needed to be'
The tennis champion said she wants to be transparent, and also to counter the idea that it's an easy way out. Serena Williams is opening up about her fitness journey, revealing that she uses the injectable GLP-1 weight loss drug Zepbound, combined with consistent exercise and a healthy diet. The 23-time Grand Slam tennis champion, 43, told Today that she wants to be transparent about her weight loss, while also countering the negative perception of a GLP-1 treatment that it's a lazy way to lose weight. GLP-1 is short for glucagon-like peptide-1 receptor agonists, and it's a type of medication that's usually prescribed for diabetes, but is also used for weight management. The medication works in the brain to affect appetite and satiety. 'I had never taken shortcuts in my career and always worked really hard. I know what it takes to be the best,' Williams told People this week. 'So it was very frustrating to do all the same things and never be able to change that number on the scale or the way my body looked.' The Olympic gold medalist told Today that after having her two daughters, Olympia in 2017 and Adira in 2023, 'I was never able to be at a healthy weight that I could be at, whether it was my joints or blood sugar levels, it was just always something that I suffered with.' The tennis star said no matter what she did, she always felt like her body was missing something. 'I'm playing professional tennis, I'm literally training five hours a day, and I would always work my way to one point on the scale, and it would never go below that,' she explained. When GLP-1's first became available, Williams said to herself: 'No way, no how, that's not for me.' But then her mindset changed, and she looked at weight loss as an opponent, just like in professional tennis. 'I can't beat this opponent, no matter what I do; I have to try something different. Tried something different, it didn't work,' she recalled on the Today show. 'I saw my friends using [GLP-1's], saw a lot of people on it, and I tried it, and it actually worked.' She told People that she has lost over 31 pounds since she used Zepbound for additional weight loss support. Williams obtained the medication through Ro, which is a direct-to-patient health care company. She is now a celebrity patient ambassador for the company. Williams's husband, Alexis Ohanian, also serves on its board and is an investor in the company. 'They were super supportive, and it was easy to get the medication,' Williams told People. While GLP-1 treatments have been approved by the FDA for weight management, and not just for diabetics, there are still some hurdles people have to overcome, like meeting certain BMI requirements, finding a licensed provider, or covering expensive out-of-pocket costs for the treatment if their insurance provider doesn't cover weight loss treatments. 'GLP-1 helped me enhance everything that I was already doing — eating healthy and working out, whether it was as a professional athlete at the top level of tennis or just going to the gym every day,' she says. 'So I think that it's important for everyone to hear my story. And I feel like there's a lot of people that can relate.' With her two daughters, Williams prioritizes conversations about body image and body positivity. 'With me going through what I've went through growing up in public and just having millions of people commenting on my body, it's really important to teach them to be confident at any size, just like I try to be,' she told People. For now, Williams is taking the weekly GLP-1 injections and trains for a half-marathon (13.1 miles). She also continues to post selfies from the gym, her 'favorite place to be.' Solve the daily Crossword
Associated Press
an hour ago
- Associated Press
BioEcho Unveils EchoLUTION™ Cell Culture RNA Kit, Delivering Superior Quality and Speed for Research
BioEcho launches new EchoLUTION™ Cell Culture RNA kit, offering superior quality and speed for academic and biopharma research in under 10 minutes. COLOGNE, GERMANY, August 21, 2025 / / -- BioEcho Life Sciences GmbH, an Admera Health company, has launched its new EchoLUTION™ Cell Culture RNA purification kit. This kit utilizes the revolutionary one-step EchoLUTION™ technology to deliver superior RNA quality with high recovery rates and more usable reads in downstream applications. The purification method drastically reduces hands-on time and overall turnaround, with a workflow of under 10 minutes. The launch of the Cell Culture RNA kit follows the successful introduction of the EchoLUTION™ FFPE RNA kit in late 2023. Both kits are critical tools for academic and biopharma researchers, offering significant cost savings by eliminating multiple wash steps and reducing the use of consumables. The new kit is available in 96- and 384-well plate formats and can be used with a variety of sample types. This new approach inverts the logic of traditional purification, which has for decades relied on harsh, inefficient binding techniques. By retaining impurities and allowing the nucleic acids to pass through in a single step, the method eliminates multiple wash steps, which are a major source of sample loss and time consumption. 'We are proud to introduce a product that will significantly improve the efficiency and quality of nucleic acid purification workflows,' said Dr. Sarah Eckenrode, General Manager of BioEcho. 'The EchoLUTION™ Cell Culture RNA kit is a game-changer for academic and biopharma researchers who need fast, reliable, and cost-effective solutions. We developed this kit to address the common bottlenecks associated with traditional methods, providing a gentle yet powerful alternative that truly reveals the unseen.' The new EchoLUTION™ Cell Culture RNA kit is a critical tool for researchers in academic and biopharma labs. It is available in 96- and 384-well plate formats and can be used with a variety of sample types. About BioEcho Life Sciences GmbH BioEcho Life Sciences is an ISO 9001 certified company specializing in nucleic acid sample preparation tools for life sciences research, agricultural, and industrial applications. Founded in 2016 by a team of industry experts in genomic sample preparation, BioEcho was established with the mission of utilizing its proprietary technologies and technical expertise to overcome the limitations of many standardized methods in molecular biology workflows. BioEcho kits offer customers industry-leading quality, speed, simplicity, and sustainability for the purification of high-quality nucleic acids from a wide variety of samples. Our mission is to provide simple, safe, and sustainable solutions that enable our customers to reveal the unseen and echoing true biology. For more information, visit Sarah Eckenrode BioEcho Life Sciences [email protected] Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Yahoo
an hour ago
- Yahoo
Serena Williams reveals she uses GLP-1 weight loss drug Zepbound: 'I just could never get back to where I needed to be'
The tennis champion said she wants to be transparent, and also to counter the idea that it's an easy way out. Serena Williams is opening up about her fitness journey, revealing that she uses the injectable GLP-1 weight loss drug Zepbound, combined with consistent exercise and a healthy diet. The 23-time Grand Slam tennis champion, 43, told Today that she wants to be transparent about her weight loss, while also countering the negative perception of a GLP-1 treatment that it's a lazy way to lose weight. GLP-1 is short for glucagon-like peptide-1 receptor agonists, and it's a type of medication that's usually prescribed for diabetes, but is also used for weight management. The medication works in the brain to affect appetite and satiety. 'I had never taken shortcuts in my career and always worked really hard. I know what it takes to be the best,' Williams told People this week. 'So it was very frustrating to do all the same things and never be able to change that number on the scale or the way my body looked.' The Olympic gold medalist told Today that after having her two daughters, Olympia in 2017 and Adira in 2023, 'I was never able to be at a healthy weight that I could be at, whether it was my joints or blood sugar levels, it was just always something that I suffered with.' The tennis star said no matter what she did, she always felt like her body was missing something. 'I'm playing professional tennis, I'm literally training five hours a day, and I would always work my way to one point on the scale, and it would never go below that,' she explained. When GLP-1's first became available, Williams said to herself: 'No way, no how, that's not for me.' But then her mindset changed, and she looked at weight loss as an opponent, just like in professional tennis. 'I can't beat this opponent, no matter what I do; I have to try something different. Tried something different, it didn't work,' she recalled on the Today show. 'I saw my friends using [GLP-1's], saw a lot of people on it, and I tried it, and it actually worked.' She told People that she has lost over 31 pounds since she used Zepbound for additional weight loss support. Williams obtained the medication through Ro, which is a direct-to-patient health care company. She is now a celebrity patient ambassador for the company. Williams's husband, Alexis Ohanian, also serves on its board and is an investor in the company. 'They were super supportive, and it was easy to get the medication,' Williams told People. While GLP-1 treatments have been approved by the FDA for weight management, and not just for diabetics, there are still some hurdles people have to overcome, like meeting certain BMI requirements, finding a licensed provider, or covering expensive out-of-pocket costs for the treatment if their insurance provider doesn't cover weight loss treatments. 'GLP-1 helped me enhance everything that I was already doing — eating healthy and working out, whether it was as a professional athlete at the top level of tennis or just going to the gym every day,' she says. 'So I think that it's important for everyone to hear my story. And I feel like there's a lot of people that can relate.' With her two daughters, Williams prioritizes conversations about body image and body positivity. 'With me going through what I've went through growing up in public and just having millions of people commenting on my body, it's really important to teach them to be confident at any size, just like I try to be,' she told People. For now, Williams is taking the weekly GLP-1 injections and trains for a half-marathon (13.1 miles). She also continues to post selfies from the gym, her 'favorite place to be.' Solve the daily Crossword
